AEMD · Aethlon Medical Inc · Executive Compensation
$6.45
-0.18 (-2.71%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 10, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$4.54M
Shares
711,136
Volume · Oct 2
40.93K
Avg daily vol (43 sessions)
3.79M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $826,922 |
| Steven P. LaRosa | Chief Medical Officer | $593,480 |
| Guy F. Cipriani | Former Senior Vice President, Chief Operating Officer | $211,250 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $500,000 |
| Steven P. LaRosa | Chief Medical Officer | $480,000 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $395,688 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Charles J. Fisher, Jr. | Jr., M.D. Former Chief Executive Officer | $505,332 |
| Charles Fisher | Jr., M.D. Former Chief Executive Officer | $505,332 |
| Steven P. LaRosa | Chief Medical Officer | $430,000 |
| James B. Frakes | Chief Executive Officer and Chief Financial Officer | $416,449 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $378,064 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Charles Fisher | Jr., M.D. Former Chief Executive Officer | $460,000 |
| Charles J. Fisher, Jr. | Jr., M.D. Former Chief Executive Officer | $460,000 |
| Steven P. LaRosa | Chief Medical Officer | $430,000 |
| Guy F. Cipriani | Senior Vice President, Chief Operating Officer | $347,500 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Charles Fisher | Jr., M.D. Chief Executive Officer | $2,477,896 |
| Charles J. Fisher, Jr. | Jr., M.D. Chief Executive Officer | $2,477,896 |
| Steven P. LaRosa | Chief Medical Officer | $792,614 |
| Guy F. Cipriani | Senior Vice President, Chief Business Officer | $772,880 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $862,563 |
| Timothy Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $862,563 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $581,661 |
| Steven P. LaRosa | CHIEF MEDICAL OFFICER | $480,449 |
| Charles J. Fisher, Jr. | Jr., M.D. CHIEF EXECUTIVE OFFICER | $474,941 |
| Charles Fisher | Jr., M.D. CHIEF EXECUTIVE OFFICER | $474,941 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $595,000 |
| Timothy Rodell | M.D., FCCP FORMER CHIEF EXECUTIVE OFFICER | $595,000 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $354,750 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Timothy C., Rodell | M.D., FCCP CHIEF EXECUTIVE OFFICER | $729,138 |
| Timothy Rodell | M.D., FCCP CHIEF EXECUTIVE OFFICER | $729,138 |
| James B. Frakes | CHIEF FINANCIAL OFFICER, SECRETARY AND SVP-FINANCE | $285,833 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Chetan S. Shah, MD | director | Appointed | 2026-10-01 |
| Angela Rossetti | director | Appointed | 2026-10-01 |
| Nicolas Gikakis | director | Appointed | 2026-10-01 |
| James B. Frakes | director | Appointed | 2026-10-01 |
| Edward G. Broenniman | director | Appointed | 2026-10-01 |
| Angela Rossetti | director | Appointed | 2026-02-23 |
| Chetan S. Shah, MD | director | Appointed | 2026-02-23 |
| Nicolas Gikakis | director | Appointed | 2026-02-23 |
| James B. Frakes | director | Appointed | 2026-02-23 |
| Edward G. Broenniman | director | Appointed | 2026-02-23 |
| James B. Frakes | permanent Chief Executive Officer | Appointed | 2024-10-03 |
| Chetan S. Shah, MD | director | Appointed | 2024-10-02 |
| Angela Rossetti | director | Appointed | 2024-10-02 |
| James B. Frakes | director | Appointed | 2024-10-02 |
| Nicolas Gikakis | director | Appointed | 2024-10-02 |
| Edward G. Broenniman | director | Appointed | 2024-10-02 |
| Charles J. Fisher, Jr., M.D. | Director | Resigned | 2023-11-27 |
| Guy F. Cipriani | Senior Vice President and Chief Operating Officer | Appointed | 2023-11-13 |
| James B. Frakes | member of the Board of Directors | Appointed | 2023-11-13 |
| James B. Frakes | Interim Chief Executive Officer | Appointed | 2023-11-13 |
| Guy F. Cipriani | Director | Resigned | 2023-11-13 |
| Nicolas Gikakis | member of the Board | Appointed | 2023-07-06 |
| Chetan S. Shah, MD | member of the Board | Appointed | 2022-09-19 |
| Charles J. Fisher, Jr., MD | member of the Board | Appointed | 2022-09-19 |
| Guy F. Cipriani | member of the Board | Appointed | 2022-09-19 |